AbbVie Faces Suit Over Delays In Generic Blood Pressure Med
AbbVie has been hit with a suit in California federal court accusing the drug giant of reaping millions of dollars in profits by paying off competitors to delay generic forms of...To view the full article, register now.
Already a subscriber? Click here to view full article